Skip to main content
SpringerLink
Log in

Radioiodine Therapy of Hyperthyroidism

  • Chapter
  • First Online:
Clinical Applications of Nuclear Medicine Targeted Therapy

  • 1017 Accesses

Abstract

Thyroid benign disorders have been successfully treated by means of administration of 131iodine since the 1940s. The efficacy and safety of this treatment and the advantages over thyroid surgery made its success worldwide. In this chapter we outline indication, Patients preparation and precautions regarding radioiodine. We also discuss the procedures and the safety and side effects of this treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Chapman EM. History of the discovery and early use of radioactive iodine. JAMA. 1983;250(15):2042–4.

    Article  CAS  PubMed  Google Scholar 

  2. Stokkel MPM, Handkiewicz DJ, Lassmann M, et al. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37:2218–28.

    Article  PubMed  Google Scholar 

  3. Silberstein EB, Abass A, Balon HR, et al. The SNM practice guideline for therapy of thyroid disease with 131I 3.0. JNM. 2012;53(10):1633–51.

    Article  PubMed  Google Scholar 

  4. Rivkees SA. Controversies in the management of Graves’ disease in children. J Endocrinol Investig. 2016;39:1247–57.

    Article  CAS  Google Scholar 

  5. Cooper DS. Hyperthyroidism. Lancet. 2003;362:459–68.

    Article  CAS  PubMed  Google Scholar 

  6. Franklyn JA. The management of hyperthyroidism. N Engl J Med. 1994;330:1731–8.

    Article  CAS  PubMed  Google Scholar 

  7. McDermott MT, Woodmansee WW, Haugen BR, et al. The management of subclinical hyperthyroidism by thyroid specialists. Thyroid. 2003;13:1133–9.

    Article  PubMed  Google Scholar 

  8. Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Carle A, Andersen SL, Boelaert K, et al. Management of endocrine disease: subclinical thyrotoxicosis: prevalence, causes and choice of therapy. Eur J Endocrinol. 2017;176(6):R325–37. https://doi.org/10.1530/EJE-16-0276.

    Article  CAS  PubMed  Google Scholar 

  10. Wesche MF, Tiel-V Buul MM, Lips P, et al. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab. 2001;86:998–1005.

    Article  CAS  PubMed  Google Scholar 

  11. Braga M, Walpert N, Burch HB, et al. The effect of methimazole on cure rates after radioiodine treatment for Graves’ hyperthyroidism: a randomized clinical trial. Thyroid. 2002;12:135–9.

    Article  CAS  PubMed  Google Scholar 

  12. Santos RB, Romaldini JH, Ward LS. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves’ disease. Thyroid. 2004;14:525–30.

    Article  CAS  PubMed  Google Scholar 

  13. West JD, Cheetham TD, Dane C, et al. Should radioiodine be the first-line treatment for paediatric Graves’ disease? – review article. J Pediatr Endocrinol Metab. 2015;28(7-8):797–804.

    Article  CAS  PubMed  Google Scholar 

  14. Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid. 2002;12:399–405.

    Article  CAS  PubMed  Google Scholar 

  15. Lazarus JH. Guidelines for the use of radioiodine in the management of hyperthyroidism: a summary. The Radioiodine Audit Subcommittee of the Royal College of Physicians Committee on Diabetes and Endocrinology, and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond. 1995;29:464–9.

    CAS  PubMed  Google Scholar 

  16. Collier A, Gosh S, Hair M, et al. Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves’ disease. Hormones (Athens). 2009;8:273–8.

    Article  Google Scholar 

  17. Hagen GA, Ouellette RP, Chapman EM. Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis. N Engl J Med. 1967;277(11):559–62.

    Article  CAS  PubMed  Google Scholar 

  18. Bachmann J, Kobe C, Bor S, et al. Radioiodine therapy for thyroid volume reduction of large goitres. Nucl Med Commun. 2009;30:466–71.

    Article  PubMed  Google Scholar 

  19. Rivkees SA, Sklar C, Freemark M. Clinical review 99: the management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab. 1998;83:3767–76.

    CAS  PubMed  Google Scholar 

  20. Ma C, Kuang A, Xie J, et al. Radioiodine treatment for pediatric Graves’ disease. Cochrane Database Syst Rev. 2008;3:CD006294.

    Google Scholar 

  21. Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics. 2003;111(4 Pt 1):745–9.

    Article  PubMed  Google Scholar 

  22. Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008;158:273–85.

    Article  CAS  PubMed  Google Scholar 

  23. Hall P, Berg G, Bjelkengren G, et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer. 1992;50:886–90.

    Article  CAS  PubMed  Google Scholar 

  24. Hall P, Boice JD, Berg G, et al. Leukaemia incidence after iodine-131 exposure. Lancet. 1992;340:1–4.

    CAS  PubMed  Google Scholar 

  25. Dobyns BM, Sheline GE, Workman JB, et al. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab. 1974;38:976–98.

    Article  CAS  PubMed  Google Scholar 

  26. Read CH, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocrinol Metab. 2004;89:4229–33.

    Article  CAS  PubMed  Google Scholar 

  27. Royal College of Physicians. Radioiodine in the management of benign thyroid disease: clinical guidelines. Report of a Working Party. London: RCP; 2007.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Unit, Humanitas Research Hospital, Rozzano, MI, Italy

    Giovanna Pepe & Gennaro Cusato

Authors
  1. Giovanna Pepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gennaro Cusato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanna Pepe .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Humanitas Gavazzeni Hospital, Bergamo, Italy

    Emilio Bombardieri

  2. Nuclear Medicine Therapy and Endocrinology, Istituto Nazionale dei Tumori, Milano, Italy

    Ettore Seregni

  3. Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy

    Laura Evangelista

  4. Nuclear Medicine Division, Istituto Nazionale dei Tumori, Milano, Italy

    Carlo Chiesa

  5. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Arturo Chiti

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pepe, G., Cusato, G. (2018). Radioiodine Therapy of Hyperthyroidism. In: Bombardieri, E., Seregni, E., Evangelista, L., Chiesa, C., Chiti, A. (eds) Clinical Applications of Nuclear Medicine Targeted Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-63067-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63067-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63066-3

  • Online ISBN: 978-3-319-63067-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation